Surrogate Endpoint (Marker): Definition and Examples
Cancers | Free Full-Text | The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Surrogate Markers and its role in the Drug Development Process - ppt video online download
2 Review: Evaluating and Regulating Biomarker Use | Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease |The National Academies Press
Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review | PLOS ONE
PPT - Statistical Evaluation of Surrogate Markers: Validity, Efficiency and Sensitivity PowerPoint Presentation - ID:710860
Surrogate Markers and its role in the Drug Development Process - ppt video online download
PDF) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*
Tumor marker /Cancer Biomarkers (Updated)
PDF) Disease vocabulary size as a surrogate marker for physicians' disease knowledge volume
Loss of SDHB expression in SDHx-driven paragangliomas. Loss of SDHB... | Download Scientific Diagram
2 Review: Evaluating and Regulating Biomarker Use | Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease |The National Academies Press
Frontiers | Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group
Biomarkers of Chronic Kidney Disease - ppt download
Surrogate Endpoints And FDA's Accelerated Approval Process | Health Affairs
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
Biomarkers - an overview | ScienceDirect Topics
IJMS | Free Full-Text | Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis
Surrogate vascular input function measurements from the superior sagittal sinus are repeatable and provide tissue-validated kinetic parameters in brain DCE-MRI | Scientific Reports
Biomarkers—A General Review - Aronson - 2017 - Current Protocols in Pharmacology - Wiley Online Library
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials - The Lancet Diabetes & Endocrinology
